Sotuvning operatsion marjasi: Liminatus Pharma Inc. (LIMN)

Liminatus (LIMN) kompaniyasining korporativ logotipi

Liminatus Pharma (LIMN) kompaniyasining operatsion foyda marjasi tarixi murakkab qattiq o'smalarga qarshi CAR-T terapiyasining salohiyatini namoyish etadi. Biroq, tadqiqotlarning to'liq tashqi pudratchilarga topshirilishi va oshqozon saratoni sinovlarining boshlanishi kutilayotgani bosim yaratmoqda. 0.00 darajasi joriy daromadlilik miqdorini aks ettiradi, bunda tijoratlashtirishdan oldingi operatsion xarajatlar bozor tomonidan allaqachon hisobga olingan.

LIMN: liminatuspharma.com Operatsion foyda normasi 02.05.2025 - 20.11.2026

Liminatus Pharma - tahliliy kesimlar va asosiy koʻrsatkichlar (LIMN)

- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning asosiy tahlili:LIMN, Liminatus Pharma LLC
Liminatus asosiy tovari

Investorlar Liminatus Pharma (LIMN) kompaniyasining barqarorligini operatsion foyda marginasi orqali bahlamoqdalar, u foizlar va soliqlar to'lanishidan oldingi operatsion daromadning umumiy tushumga nisbati sifatida hisoblanadi. Kompaniyaga tegishli operatsion marginasini tahlil qilish orqali geosiyosiy risklar va Osiyo xomashyolari yetkazib berish zanjiridagi uzilishlarning immuno-onkologik dori vositalarining haqiqiy ishlab chiqarish samaradorligiga ta'sirini aniqlash mumkin.

Liminatus Pharma kimlar bilan raqobatlashadi

Sotuvning operatsion marjasi IBRX|IMCR - Operatsion foyda bo'yicha marjinallik|Sotuvning operatsion marjasi JANX (Janux Pharma)|Operatsion foyda koeffitsiyenti RCUS|Operatsion marja ZYME (Zymeworks)|Operatsion foyda normasi TNGX|iovance.com - Operatsion marja|Sotuvning operatsion rentabelligi Immatics Biotechnologies|Xencor, Inc. (XNCR) - Operatsion rentabellik|Compass Therapeutics - Operatsion foyda normasi|REPL (replimune.com) - Operatsion marja|Operatsion marja Lyell|Operatsion rentabellik Innate Pharma (IPHA)|PYXS: Operatsion foyda marjasi|Compugen - Sotuvning operatsion marjasi|IO Biotech, Inc. (IOBT) - Sotuvning operatsion rentabelligi|STRO - Operatsion rentabellik|MiNK Therapeutics (INKT) - Sotuvning operatsion marjasi|HOWL: Operatsion marja|Sotuvning operatsion marjasi Immix|Sotuvning operatsion marjasi ALXO|CUE: Operatsion foyda normasi|Sotuvning operatsion marjasi PDSB (PDS Biotech)|Sonnet BioTherapeutics Holdings - Operatsion foyda bo'yicha sotuv rentabelligi|MAIA Biotechnology Inc - Sotuvning operatsion marjasi|Operatsion foyda normasi LVTX|NXTC: Sotuvning operatsion marjasi|leaptx.com - Operatsion foyda koeffitsiyenti|INTS: Operatsion marja|Sensei Biotherapeutics Inc - Operatsion foyda normasi|Sotuvning operatsion marjasi TOVX|Operatsion foyda bo'yicha sotuv rentabelligi GRTS (Gritstone bio, Inc.)|Sotuvning operatsion marjasi KA (kinetabio.com)|NEXI - Sotuvning operatsion rentabelligi|Turnstone Biologics - Sotuvning operatsion marjasi|Operatsion faoliyat rentabelligi Vaccinex Inc. (VCNX)|harpoontx.com - Operatsion marja